Regulation of L-type calcium channel by phospholemman in cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 84, Issue , 2015, Pages 104-111

  Zhang, Xue Qian ^a   Wang, JuFang ^a   Song, Jianliang ^a   Rabinowitz, Joseph ^a   Chen, Xiongwen ^a   Houser, Steven R ^a   Peterson, Blaise Z ^b   Tucker, Amy L ^c   Feldman, Arthur M ^a   Cheung, Joseph Y ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Arrhythmia; Ca2+ channels; FXYD1; Phospholemman

Indexed keywords

ADENOVIRUS VECTOR; ALANINE; BARIUM ION; CALCIUM CHANNEL L TYPE; CALCIUM ION; GREEN FLUORESCENT PROTEIN; ISOPRENALINE; PHOSPHOLEMMAN; PHOSPHOPROTEIN; SERINE; UNCLASSIFIED DRUG; CACNA1C PROTEIN, MOUSE; MEMBRANE PROTEIN; MUTANT PROTEIN; PHOSPHOSERINE;

ADULT; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOG; ELECTRIC POTENTIAL; HEART CELL CULTURE; HEART MUSCLE CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; VIRAL GENE DELIVERY SYSTEM; WILD TYPE MOUSE; ADENOVIRIDAE; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; CHANNEL GATING; CHEMISTRY; CYTOPLASM; DRUG EFFECTS; HEART VENTRICLE; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ADENOVIRIDAE;

ADENOVIRIDAE; AMINO ACID MOTIFS; ANIMALS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; CYTOPLASM; DOGS; HEART VENTRICLES; ION CHANNEL GATING; ISOPROTERENOL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTANT PROTEINS; MYOCYTES, CARDIAC; PHOSPHOPROTEINS; PHOSPHOSERINE; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84928745519     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.04.017     Document Type: Article

References (43)

1. Palmer C.J., Scott B.T., Jones L.R. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 1991, 266:11126-11130.
2. Presti C.F., Jones L.R., Lindemann J.P. Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem 1985, 260:3860-3867.
3. Crambert G., Fuzesi M., Garty H., Karlish S., Geering K. Phospholemman (FXYD1) associates with Na, K-ATPase and regulates its transport properties. Proc Natl Acad Sci U S A 2002, 99:11476-11481.
4. Bossuyt J., Ai X., Moorman J.R., Pogwizd S.M., Bers D.M. Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ Res 2005, 97:558-565.
5. Fuller W., Eaton P., Bell J.R., Shattock M.J. Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J 2004, 18:197-199.
6. 2+ exchanger, phospholemman. J Biol Chem 2005, 280:19875-19882.
7. i transients in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2004, 286:H1322-H1330.
8. Wang X., Gao G., Guo K., Yarotskyy V., Huang C., Elmslie K.S., et al. Phospholemman modulates the gating of cardiac L-type calcium channels. Biophys J 2010, 98:1149-1159.
9. Despa S., Bossuyt J., Han F., Ginsburg K.S., Jia L.G., Kutchai H., et al. Phospholemman-phosphorylation mediates the β-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 2005, 97:252-259.
10. Despa S., Tucker A., Bers D. PLM-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during β-adrenergic stimulation in mouse ventricular myocytes. Circulation 2008, 117:1849-1855.
11. Wang J., Gao E., Song J., Zhang X.Q., Li J., Koch W.J., et al. Phospholemman and β-adrenergic stimulation in the heart. Am J Physiol Heart Circ Physiol 2010, 298:H807-H815.
12. 2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2003, 284:H225-H233.
13. 2+ exchanger. Role of phosphorylation. J Biol Chem 2006, 281:7784-7792.
14. 2+ exchange. Am J Physiol Heart Circ Physiol 2011, 300:H859-H868.
15. 2+ exchange. Am J Physiol Heart Circ Physiol 2006, 291:H2199-H2209.
16. Jia L.G., Donnet C., Bogaev R.C., Blatt R.J., McKinney C.E., Day K.H., et al. Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice. Am J Physiol Heart Circ Physiol 2005, 288:H1982-H1988.
17. Zhou Y.Y., Wang S.Q., Zhu W.Z., Chruscinski A., Kobilka B.K., Ziman B., et al. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol 2000, 279:H429-H436.
18. +-ATPase. Am J Physiol Heart Circ Physiol 2008, 295:H1615-H1625.
19. Brown A.M., Lee K.S., Powell T. Sodium current in single rat heart muscle cells. J Physiol 1981, 318:479-500.
20. Benndorf K., Boldt W., Nilius B. Sodium current in single myocardial mouse cells. Pflugers Arch 1985, 404:190-196.
21. i transients in adult rat myocytes. Am J Physiol Heart Circ Physiol 2002, 283:H576-H583.
22. 2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2005, 288:H2342-H2354.
23. 2+ contents and action potential duration. Am J Physiol Heart Circ Physiol 2009, 297:H590-H601.
24. 2+ exchanger does not aggravate myocardial dysfunction induced by transverse aortic constriction. J Card Fail 2013, 19:60-70.
25. 2+ exchanger. Am J Physiol Heart Circ Physiol 2012, 302:H770-H781.
26. Guo K., Wang X., Gao G., Huang C., Elmslie K.S., Peterson B.Z. Amino acid substitutions in the FXYD motif enhance phospholemman-induced modulation of cardiac L-type calcium channels. Am J Physiol Cell Physiol 2010, 299:C1203-C1211.
27. +-ATPase by phospholemman (FXYD1). Adv Exp Med Biol 2013, 961:175-190.
28. V1.2 via the β-adrenergic-cAMP-protein kinase A pathway: old dogmas, advances, and new uncertainties. Circ Res 2013, 113:617-631.
29. V1.2 calcium channels: from in vitro findings to in vivo function. Physiol Rev 2014, 94:303-326.
30. McDonald T.F., Pelzer S., Trautwein W., Pelzer D.J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev 1994, 74:365-507.
31. 2+ channel gating differentially modulated by physiological stimuli. Am J Physiol 1990, 258:H1872-H1881.
32. Bean B.P. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A 1984, 81:6388-6392.
33. Yasui K., Palade P. Inhibitory action of SR33557 on L-type calcium current in single ventricular myocytes of rat. Br J Pharmacol 1995, 114:468-474.
34. Waalas S.I., Czernik A.J., Olstad O.K., Sletten K., Walaas O. Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J 1994, 304(Pt 2):635-640.
35. Shinoda T., Ogawa H., Cornelius F., Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 2009, 459:446-450.
36. Armoundas A.A., Hobai I.A., Tomaselli G.F., Winslow R.L., O'Rourke B. Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res 2003, 93:46-53.
37. Shattock M.J., Bers D.M. Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am J Physiol Cell Physiol 1989, 256:C813-C822.
38. Fuller W., Howie J., McLatchie L., Weber R., Hastie C.J., Burness K., et al. Fxyd1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol 2009, 296:C1346-C1355.
39. Rembold C.M., Ripley M.L., Meeks M.K., Geddis L.M., Kutchai H.C., Marassi F.M., et al. Serine68 phospholemman phosphorylation during forskolin-induced swine carotid artery relaxation. J Vasc Res 2005, 42:483-491.
40. + pump activity in post-infarction myocytes. J Appl Physiol 2006, 100:212-220.
41. Silverman B.D., Fuller W., Eaton P., Deng J., Moorman J.R., Cheung J.Y., et al. Serine68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res 2005, 65:93-103.
42. Cheung J.Y., Zhang X.Q., Song J., Gao E., Rabinowitz J., Chan T.O., et al. Phospholemman: a novel cardiac stress protein. Clin Transl Sci 2010, 3:189-196.
43. Mirza M.A., Lane S., Yang Z., Karaoli T., Akosah K., Hossack J., et al. Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality. Clin Transl Sci 2012, 5:235-242.